Regen BioPharma Inc (RGBP)

[SidVicious]

Ang, a better run company with a more knowledgeable CEO would have not had the delays Koos has had with Hema. Hema was delayed almost 3 years because of poor planning and cutting corners. Take for instance the safety studies. The first set the company cut corners by using a cheaper non GLP lab. The FDA came back and said you need to use a GLP lab for safety studies. We can talk all day long about the technology but frankly, all of it doesn't mean squat if it doesn't prove to work in human. And thus why trials are needed. If Hema works in the upcoming trial, whenever that will start, then Regen will hopefully be sitting pretty. But there are still things to worry about.

1.What if Hema doesn't work? Uh oh. many on here for the longest time made claims it works without it ever being used in humans. Frankly, that's talk from those who lack a basic understanding of medicine, science and how the drug process works.

2.Hema works but no major pharma cares enough to want to buy it from Regen to further it in clinical studies. Contrary to popular demand on here, success in P1 doesn't mean the drug is approved for marketing. More studies will be needed. so if no other company steps up, how will REGEN fund P2 trials? It can't.

3.Hema works, pharma company steps up but won't pay what REGEN wants? What then? Will Koos let Hema go and get a fraction of what he wants. Remember, Koos and REGEN have no bargaining power at all. It is desperate for cash.

Think hard about this because let's remember that the pie in the sky claims made on here have NEVER EVER come true in regards to how REGEN would trade if certain milestones were met.